MedTrace Logo

MARCH Vascular Endothelium Substudy

NCT01585753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2016-01-20

No results posted yet for this study

Summary

This is a substudy of MARCH, in which we are exploring the changes in the vascular endothelium using pulse wave tonometry (a non invasive measure of cardiac health) to measure the changes in small and large arterial elasticity in participants of the MARCH study who switch to maraviroc-based regimens over 96 weeks of follow-up.

Conditions

Interventions

DRUG

NRTI + PI

tenofovir zidovudine abacavir lamivudine emtricitabine ritonavir darunavir atazanavir lopinavir fosamprenavir

DRUG

maraviroc + PI

maraviroc ritonavir darunavir atazanavir lopinavir fosamprenavir

DRUG

maraviroc + NRTI

maraviroc tenofovir zidovudine abacavir lamivudine emtricitabine

Sponsors & Collaborators

  • Kirby Institute

    lead OTHER_GOV

Principal Investigators

  • Sarah L Pett, FRACP,FRCPE,PhD · Kirby Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Argentina
  • Australia
  • Germany
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585753 on ClinicalTrials.gov